Clinical Trials Directory

Trials / Completed

CompletedNCT06883461

Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics

A Cross-sectional Study Exploring the Proteomic Association of Serum Extracellular Vesicles in Patients with Age-related Macular Degeneration and Cognitive Impairment Using LC-MS/MS

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
40 Years – 100 Years
Healthy volunteers
Accepted

Summary

Aim: Preliminary serum exosomal proteomics of patients with dry age-related macular degeneration (AMD) and mild cognitive impairment (MCI) were analyzed using proteomics technology. Methods: Peripheral serum samples were collected from patients with AMD, MCI, comorbid conditions, and the control group. Exosomes were isolated from these samples and analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Differentially expressed proteins (DEPs) associated with the two diseases were identified based on fold change and p-value. DEPs were analyzed by Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) network analysis. Western blot and enzyme-linked immunosorbent assay (ELISA) were used to validate the DEPs of interest.

Conditions

Timeline

Start date
2019-04-01
Primary completion
2024-06-03
Completion
2024-06-03
First posted
2025-03-19
Last updated
2025-03-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06883461. Inclusion in this directory is not an endorsement.